Small diameter melanoma: a follow-up of the Norwegian Melanoma Project.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15541089.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Melanoma prognosis is dependent upon early recognition and treatment. There is a need for good clinical guidelines that focus on the early signs of melanoma. The ABCD (asymmetry, border, colour and diameter) rule states that most melanomas are more than 6 mm in diameter. Critics crave a modification, arguing that small diameter melanomas are not infrequent. The aim of the present study was to describe the frequency and prognosis of melanomas less than 7 mm in a clinical setting. The Norwegian Melanoma Project was conducted as a multicentre, prospective study with inclusion criteria. Patients were recruited from five dermatological departments in Norway from 1990 to 1993. The frequency of small melanomas was 11.4% (18/158). One-third was in situ melanoma, the rest invasive with a median thickness of 0.8 mm. Four small melanomas were T2 lesions, with a Breslow thickness of more than 1 mm. One nodular T2 melanoma recurred locally 2 years after diagnosis and the patient died of distant metastasis only months later. The ABCD rule remains a practical guide for early recognition of melanoma. Clinicians must be aware of its limitations.
Medical subject headings
- Melanoma
- Skin Neoplasms